Innovative Investment

Preface


Entrepreneurial investment is a hot spot in the investment market.

Currently, China's innovative industries have gradually become the focus of the investment market. By 2022, the number of investment cases in information technology, semiconductors, biomedicine, and intelligent manufacturing related fields will account for more than 70% of the total investment market.

By 2022, China's total innovation investment scale is about RMB 27 billion yuan. The financing scale for IPOs exceeds RMB 400 billion yuan and 300 companies have completed IPOs.


QFLP allows free access to mainland primary markets

Qualified Foreign Limited Partner (QFLP) is a foreign investor channel that can invest in domestic equity primary markets through licensing after qualification approval. Overseas funds can freely enter and exit investments in domestic equity primary markets through QFLP.


The key to entrepreneurial investment lies in project resources

The threshold for science and technology innovation projects is high with high difficulty requiring institutional deep mining judgment which puts higher demands on institutional industry recognition; On the other hand, high-quality projects also put very high requirements on institutions' post-investment empowerment capabilities making it difficult for general investing institutions to obtain shares of quality projects. Therefore, the most core competitiveness of science and technology innovation investments lies in available project resources.



Zenta's top project resource system


2-01.png


Zhongguancun Development Group

Zhongguancun Development Group has invested over 2500 scientific and technological projects promoting scientific achievements transformation as well as industrial parks.

2-02.png


2-03.png


China Science Academy Holdings Co., Ltd.

National Science Control represents wholly-owned subsidiaries or holding companies under Chinese Academy of Sciences providing cutting-edge hard-tech resources.

China Science Academy Holdings Co., Ltd., referred to as National Science Control was approved by State Council as first central-level state-owned asset management company operating unit representing direct investments from Chinese Academy of Sciences exercising shareholder rights including stock management, industrial integration restructuring strategic supervision according to modern enterprise system standards creating greater profit returns and equity appreciation for shareholders.


National Science Control has a registered capital of RMB 5.1 billion yuan with 51 directly held companies, including wholly-owned and holding companies in 23 provinces and cities across the country covering multiple fields such as new materials, energy conservation and environmental protection, information technology, high-end equipment manufacturing, publishing media, life health care services, science and technology finance innovation services.


At the end of 2020 National Science Control's total assets exceeded RMB720 billion yuan achieving operating income exceeding RMB430 billion yuan.


2-04.png


2-05.png


Shenzhen Investment Holdings

Science & Technology Finance Industrial Cluster

Shenzhen Investment Holdings Co., Ltd. (referred to as "SIH") was established in 2004 by merging three asset management companies: Shenzhen Investment Management Company Limited; Shenzhen Commercial Holding Group Co., Ltd.; Shenzhen Construction Holding Group Co., Ltd. It has now developed into a state-owned capital investment company mainly engaged in science & technology finance industrial cluster with total assets over RMB960 billion yuan.


Science & Technology Finance Industrial Cluster

Guosen Securities: The securities firm that serves most high-tech enterprises listed on the main board or GEM market; High-Tech Venture Capital Fund and Guarantee Group: The leading players in China's financing guarantee industry; Guoren Insurance: Innovatively launched insurance business for scientific research projects providing risk protection for technological innovation; Shenzhen Asset Management Corporation: A financial risk resolution platform focusing on non-performing asset management; Shenzhen Angel Mother Fund: With a scale of up to RMB10 billion yuan it promotes angel investors and angel projects gathering towards Shenzhen; Science & Technology Venture Capital Funds group covers various stages from angel investments to VC/PE funds mergers acquisitions throughout enterprise development lifecycle with a scale exceeding one trillion yuan.


Science Park Industry Cluster

SIH successfully developed six major industrial parks including ShenZhen Bay Tech Ecological Park、ShenZhen Software Industry Base、ShenZhen Bay Venture Capital Building、Shenzhen Bay Innovation Technology Center, Shenzhen Biomedical Innovation Industrial Park and SIH Chuangzhi Tiandi Building. Up to now, more than 50 industrial parks of various types have been planned and constructed in the entire system with a total construction area of approximately 30 million square meters providing "fertile soil" for the development of science and technology industries.

The annual output value of these parks exceeds RMB250 billion yuan with over 2,000 high-tech enterprises including unicorn companies settled in them cultivating world-class innovative industrial clusters.


Technology and high-end service industry clusters

Technology and high-end service industry clusters have a group of high-quality enterprises in the fields of semiconductors, new materials, environmental protection technology, etc., such as Seg Group, Shenzhen Textile, and Shen Huan Technology. Seg Group is a pioneer in the national electronic market industry and has developed Huaqiangbei into "China's first electronic street". Shenzhen Textile successfully transformed into a professional polarizer manufacturer and produced the first domestically produced polarizer. Shen Huan Technology is the first professional organization for hazardous waste treatment in China, receiving and disposing of more than 60% of the total amount of hazardous waste in the city.


2-06.png


Daan Gene

Daan Gene is a leader in the biopharmaceutical field with 300 incubated biopharmaceutical companies. 

Daan Chuanggu is Daan Gene's main operating management organization in the health industry ecosystem.The company explores new project investments upstream and downstream of the biopharmaceutical industry chain to incubate 300 independent innovative biopharmaceutical companies. Two are listed on Hong Kong Stock Exchange (HKEX), four are listed on Science and Technology Innovation Board (STAR Market), fifteen have entered New Third Board (NTB), five have completed stock reform while twelve will complete it soon; over ten companies are preparing to enter NTB or IPO process.


Da An Gene Co., Ltd. is a state-owned enterprise that focuses on molecular diagnostic technology research & development (R&D) for clinical testing reagents & instruments sales as well as nationwide chain medical independent laboratory clinical testing services integration bio-pharmaceutical high-tech enterprise which was listed on SZSE(002030)in 2004.Da An Gene has manufacturing capacity involving throat swabs,nucleic acid preservation solution,nucleic acid extraction reagent,new coronavirus2019-NCOV nucleic acid detection kit(fluorescent PCR method)&related equipment(full-automatic nucleic acid extractor SMART32&SP96,AGS4800 fluorescent quantitative PCR instrument)and output capacity of overall testing laboratory. Da An's new coronavirus detection kit currently ranks first in the domestic market share.


Zenta Group is committed to cooperating with top domestic technology innovation institutions and enterprises. It has established deep cooperation relationships with Daan Gene, Zhongguancun Development Group, Chinese Academy of Sciences National Science and Technology Holdings, Shenzhen Investment Control, etc., so Zenta Group has a number of national top-level investable sci-tech projects resources.



GO TOP